Scale Biosciences (ScaleBioTM), an innovator in accessible, flexible, and scalable single cell omics solutions, today announced the availability of ScalePlex an advanced single cell multiplexing technology designed to simplify large-scale single cell genomics studies. With massively parallelized single cell barcoding and effortless sample multiplexing, ScalePlex enables ultimate experimental flexibility from small to large-scale, multi-sample, multi-condition studies while generating high quality data. ScalePlex enables researchers to conduct experiments of any size and sample number seamlessly, efficiently, and cost-effectively.
It does this by overcoming the limitations of traditional lipid- or antibody-based single cell multiplexing technologies by utilizing a novel modified oligo tag added during fixation. The simple workflow eliminates the need for individual fixation and washing steps prior to sample pooling as well as eliminating upfront optimizations or titrations. By preserving precious samples, ScalePlex is particularly valuable for researchers working with small biological tissue samples, such as those used in oncology and neuroscience experiments.
The scalability and efficiency of this technology makes it possible to study a much larger number of samples and cells than is realistic with other technologies,” said Alexander Bick, M.D., Ph.
D., Assistant Professor of Medicine at Vanderbilt University Medical Center. “This new technology is unlocking the possibilit.
